.Turnstone Biologics is reducing its own headcount by 60% and shocking its own C-suite in order to a...
.In a year that has found an approval and also a plethora of readouts for metabolic dysfunction-asso...
.Alaunos Therapies is actually axing a contract with Precigen, losing hope licensing liberties to an...
.Capricor Therapies is actually taking a victory lap for their phase 2 Duchenne muscular dystrophy (...
.The FDA has actually positioned Kezar Life Sciences' lupus test on grip after the biotech flagged f...
.A phase 3 test of Academic Rock's vertebral muscle degeneration (SMA) applicant has actually struck...
.RNA biotech CAMP4 Therapeutics has marked out prepare for a $67 thousand IPO, along with inflammati...
.A year after the failing of an idiopathic pulmonary fibrosis prospect sent out Galecto on a hunt fo...
.Taking the mat is Judo Bio, a promising biotech armed with $100 million to cultivate oligonucleotid...
.AstraZeneca has paid CSPC Pharmaceutical Team $100 thousand for a preclinical heart disease medicat...